6 Results for: created: (01/2018 to 01/2018)

People

  1. Landgren
    Landgren
  2. Hultcrantz
    Hultcrantz
  3. Mailankody
    Mailankody

Groups

  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Myeloma (6)
  5. Hematologic Malignancies Research (5)
  6. Sloan Kettering Institute Postdocs (1)
  1. "Myeloma"
Formats
  1. Journal Article (5)
  2. Meeting Abstract (1)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Myeloma (6)
  5. Hematologic Malignancies Research (5)
  6. Sloan Kettering Institute Postdocs (1)
People
  1. Carl Landgren (5)
  2. Malin Hultcrantz (1)
  3. Sham Mailankody (1)
Years
  1. 2018 (1)
  2. 2017 (5)
Publications
  1. Blood Advances (1)
  2. Blood Cancer Journal (1)
  3. Clinical Pharmacology & Therapeutics (1)
  4. European Journal of Public Health (1)
  5. Hematology-American Society of Hematology Education Program (1)
  6. The Lancet Haematology (1)
Publishers
  1. American Society of Hematology (2)
  2. Nature Publishing Group (2)
  3. Elsevier Science, Inc. (1)
  4. Oxford University Press (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A benefit-risk analysis approach to capture regulatory decision-making: Multiple myeloma
    Journal Article

    Raju, G. K.; Gurumurthi, K.; Domike, R.; Kazandjian, D.; Landgren, O.; Blumenthal, G. M.; Farrell, A.; Pazdur, R.; Woodcock, J.
    Clinical Pharmacology & Therapeutics (2018)

    Fulltext@MSK | Save
  • Early life dietary pattern and risk of monoclonal gammopathy of undetermined significance
    Meeting Abstract

    Thordardottir, M.; Lindqvist, E. K.; Birgisdottir, B. E.; Steingrimsdottir, L.; Eiriksdottir, G.; Harris, T. B.; Landgren, O.; Gudnason, V.; Torfadottir, J. E.; Kristinsson, S. Y.
    European Journal of Public Health (2017)

    Fulltext@MSK | Save
  • The impact of prior malignancies on second malignancies and survival in MM patients: A population-based study
    Journal Article

    Jonsdottir, G.; Lund, S. H.; Bjorkholm, M.; Turesson, I.; Hultcrantz, M.; Porwit, A.; Jethava, Y. S.; Landgren, O.; Kristinsson, S. Y.
    Blood Advances (2017)

    Fulltext@MSK | Save
  • Serum protein markers of clonal heterogeneity in myeloma
    Journal Article

    Landgren, O.
    The Lancet Haematology (2017)

    Fulltext@MSK | Save
  • Shall we treat smoldering multiple myeloma in the near future?
    Journal Article

    Landgren, O.
    Hematology-American Society of Hematology Education Program (2017)

    Fulltext@MSK | Save
  • Clinically meaningful benefit: Real world use compared against the American and European guidelines
    Journal Article

    Dreicer, J. J.; Mailankody, S.; Fahkrejahani, F.; Prasad, V.
    Blood Cancer Journal (2017)

    Fulltext@MSK | Save